Electronic Schizophrenia Treatment Adherence Registry (e-STAR): an observational international study to evaluate treatment adherence in schizophrenia with long-acting risperidone microspheres.

Trial Profile

Electronic Schizophrenia Treatment Adherence Registry (e-STAR): an observational international study to evaluate treatment adherence in schizophrenia with long-acting risperidone microspheres.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 May 2014

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms e-STAR
  • Sponsors Janssen
  • Most Recent Events

    • 06 Nov 2010 24-month results of the preplanned cost-effectiveness analysis presented at the 13th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (EISPOR).
    • 03 Nov 2009 Actual end date (Jun 2009) and actual number of patients (230) added as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top